SEATTLE, June 21, 2018 /PRNewswire/ -- KPIT, a global technology company that specializes in IT consulting and product engineering solutions today announced a strategic collaboration with Kinetiq, the leader in life sciences and clinical research management consulting, to deliver new life sciences focused business technology applications.
The alliance strengthens the core service offerings of both organizations in supporting life sciences customers. Kinetiq will provide professional regulatory compliance consulting capabilities to KPIT customers, including software solutions engagements that require a Part 11 audit, program development, and implementation. Whereas KPIT will complement Kinetiq management consulting services with value-added custom software development, systems integration, application and infrastructure support outsourcing, testing as a service (TaaS), and project management.
"Kinetiq is excited to be collaborating with a globally recognized leader such as KPIT," said James Riddle, vice president of client services for Kinetiq. "This collaboration will offer our clients immediate access to custom software development as part of their Part 11 and Annex 11 compliance programs. We look forward to the advantages this collaboration brings to customers and partners of both organizations."
"As a worldwide leader in the delivery of custom and commercial off-the-shelf software and IT application and infrastructure support, KPIT is proud to incorporate the capabilities of Kinetiq consulting resources for our medical device and pharmaceutical industry clients," said Pawan Sharma, CEO for Solutions and Services at KPIT. "It will enhance and expand our services to provide these hugely regulated industries with integrated information technology and compliance consulting solutions for improved business outcomes."
KPIT (BSE: 532400, NSE: KPIT) is a global technology company specializing in providing IT Consulting and Product Engineering solutions and services to Automotive, Manufacturing, Energy and Utilities, and Life Sciences companies. Together with its customers and partners, it creates and delivers technologies to enable creating a cleaner, greener, and more intelligent world that is sustainable and efficient.
Director of Marketing
Quorum Review IRB